Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.336 USD | -91.91% | +52.68% | -25.50% |
Business Summary
Number of employees: 46
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Compounds
100.0
%
| 41 | 100.0 % | 49 | 100.0 % | +19.95% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 49 | 100.0 % | +19.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Eric Deng
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Jason Sausser
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Richard Ghalie
CTO | Chief Tech/Sci/R&D Officer | 66 | 16-02-29 |
David Walsey
IRC | Investor Relations Contact | - | 18-01-31 |
Eugene Park
SAM | Sales & Marketing | - | 21-06-30 |
Anne Frese
HRO | Human Resources Officer | - | 22-06-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Nick Glover
BRD | Director/Board Member | 55 | 13-06-10 |
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Steven Wood
BRD | Director/Board Member | 41 | 23-10-30 |
Director/Board Member | 33 | 23-10-30 | |
James Flynn
BRD | Director/Board Member | 43 | 23-10-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,662,857 | 6,636,883 ( 99.61 %) | 0 | 99.61 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- MEIP Stock
- 0JW9 Stock
- Company MEI Pharma, Inc.